It has been reported that MIF can affect tumor progression through some mechanisms, including interactions with COX-2 and P53 (Bach et al., 2008; Mitchell et al., 2002; Rizzo, 2011; Vousden and Prives, 2009; Xia et al., 2005). Here, TP53 is linked to neoplasm.